Literature DB >> 13307661

Trends in the treatment of tumours of the rectum, rectosigmoid and left colon.

C N MORGAN.   

Abstract

Entities:  

Keywords:  INTESTINE, LARGE/neoplasms

Mesh：

Year:  1955        PMID： 13307661

Source DB:  PubMed          Journal:  J R Coll Surg Edinb        ISSN： 0035-8835


× No keyword cloud information.
  12 in total

1.  Results of surgery in cancer of large intesine in a non-teaching hospital.

Authors:  G S ANDERSON
Journal:  Br Med J       Date:  1961-05-20

2.  Implantation from the bowel lumen in cancer of the large intestine.

Authors:  W M KEYNES
Journal:  Ann Surg       Date:  1961-03       Impact factor: 12.969

3.  Results of surgery in treatment of cancer of the large intestine.

Authors:  F G SMIDDY; J C GOLIGHER
Journal:  Br Med J       Date:  1957-04-06

4.  MODERN humours.

Authors: 
Journal:  Br Med J       Date:  1958-04-19

5.  Anastomotic recurrence of colorectal cancer.

Authors:  P F Jones
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

6.  Can radical surgery improve survival in colorectal cancer?

Authors:  J Jeekel
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

7.  Tumor recurrence in colon anastomoses: prevention by coagulation and fixation with formalin.

Authors:  H O Douglass; H H LeVeen
Journal:  Ann Surg       Date:  1971-02       Impact factor: 12.969

8.  Peroperative rectal washout using the irrigating proctoscope.

Authors:  G Goodson
Journal:  Int J Colorectal Dis       Date:  1987-02       Impact factor: 2.571

9.  Curative resection performed twice for circular-staple-line recurrence after colorectal carcinoma surgery: report of a case.

Authors:  Kazuhito Yajima; Hitoshi Matsuo; Takashi Kobayashi; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

10.  The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma.

Authors:  H C Umpleby; R C Williamson
Journal:  Ann R Coll Surg Engl       Date:  1984-05       Impact factor: 1.891
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.